Elizabeth E Hull
Overview
Explore the profile of Elizabeth E Hull including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flores B, Uppalapati C, Pascual A, Vong A, Baatz M, Harrison A, et al.
Biomolecules
. 2023 Nov;
13(11).
PMID: 38002270
The coordination of zinc by histone deacetylase inhibitors (HDACi), altering the bioavailability of zinc to histone deacetylases (HDACs), is key to HDAC enzyme inhibition. However, the ability of zinc binding...
2.
Pulford C, Uppalapati C, Montgomery M, Averitte R, Hull E, Leyva K
Int J Mol Sci
. 2022 Aug;
23(16).
PMID: 36012449
While most cases of cutaneous squamous cell carcinoma (cSCC) are benign, invasive cSCC is associated with higher mortality and is often more difficult to treat. As such, understanding the factors...
3.
Johnson E, Uppalapati C, Pascual A, Estrada S, Averitte R, Leyva K, et al.
Front Oncol
. 2022 Feb;
12:819580.
PMID: 35223500
Cutaneous squamous cell carcinoma (cSCC) is a common form of skin cancer with an estimated 750,000 cases diagnosed annually in the United States. Most cases are successfully treated with a...
4.
Pascual A, Rapanan J, Uppalapati C, Cooper K, Leyva K, Hull E
Cell Biol Int
. 2021 Mar;
45(6):1288-1295.
PMID: 33710707
There is a growing controversy about the role of the epithelial to mesenchymal transition (EMT) in the fibrosis associated with chronic disease. Recent studies suggest that it is not the...
5.
Montgomery M, Hull E
BMC Cancer
. 2019 Jan;
19(1):79.
PMID: 30651077
Background: Defects in the type and degree of cellular glycosylation impact oncogenesis on multiple levels. Although the type of glycosylation is determined by protein sequence encoded by the genome, the...
6.
Hull E, Montgomery M, Leyva K
Int J Mol Sci
. 2017 Jul;
18(7).
PMID: 28672878
Emerging evidence suggests that the enzymes in the biosynthetic pathway for the synthesis of heparan sulfate moieties of heparan sulfate proteoglycans (HSPGs) are epigenetically regulated at many levels. As the...
7.
Belden S, Uppalapati C, Pascual A, Montgomery M, Leyva K, Hull E, et al.
J Vis Exp
. 2017 Jun;
(123).
PMID: 28605380
The incidence of skin cancer (e.g., squamous cell carcinoma, basal cell carcinoma, and melanoma) has been increasing over the past several years. It is expected that there will be a...
8.
Hull E, Montgomery M, Leyva K
Biomed Res Int
. 2016 Aug;
2016:8797206.
PMID: 27556043
Histone deacetylase (HDAC) inhibitors are powerful epigenetic regulators that have enormous therapeutic potential and have pleiotropic effects at the cellular and systemic levels. To date, HDAC inhibitors are used clinically...
9.
Davis M, Daggett J, Pascual A, Lam J, Leyva K, Cooper K, et al.
BMC Cancer
. 2016 May;
16:316.
PMID: 27188282
Background: The BRM and BRG1 tumor suppressor genes are mutually exclusive ATPase subunits of the SWI/SNF chromatin remodeling complex. The human adrenal carcinoma SW13 cell line can switch between a...
10.
Rapanan J, Pascual A, Uppalapati C, Cooper K, Leyva K, Hull E
J Vis Exp
. 2015 Mar;
(96).
PMID: 25742068
Due to their unique motile properties, fish keratocytes dissociated from explant cultures have long been used to study the mechanisms of single cell migration. However, when explants are established, these...